Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Pediatric Radiology|April 23, 2010
Raccoon roundworm encephalitisPareen Mehta, Zachary Boyd, Brent CullyPhysics in Medicine and Biology|November 27, 2018
Simultaneous motion monitoring and truth-in-delivery analysis imaging framework for MR-guided radiotherapyNikolai J Mickevicius, Xinfeng Chen, Zachary Boyd, et al.Contrast Media & Molecular Imaging|December 29, 2006
MRI tumor characterization using Gd-GlyMe-DOTA-perfluorooctyl-mannose-conjugate (Gadofluorine M), a protein-avid contrast agentHans-Jürgen Raatschen, Rebecca Swain, David M Shames, et al.European Journal of Immunology|August 21, 2007
Transcriptional control of human T-BET expression: the role of Sp1Jianhua Yu, Min Wei, Zachary Boyd, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2021
Analyses of PD-L1 and Inflammatory Gene Expression Association with Efficacy of Nivolumab ± Ipilimumab in Gastric Cancer/Gastroesophageal Junction CancerMing Lei, Nathan O Siemers, Dimple Pandya, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2009
In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer modelsKlaus P Hoeflich, Carol O'Brien, Zachary Boyd, et al.Journal of Hepatology|July 26, 2020
Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinomaBruno Sangro, Ignacio Melero, Samir Wadhawan, et al.Nature|November 28, 2014
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancerThomas Powles, Joseph Paul Eder, Gregg D Fine, et al.Immunity|May 23, 2006
Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cellsJianhua Yu, Min Wei, Brian Becknell, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|January 19, 2018
Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for AtezolizumabBharathi Vennapusa, Brian Baker, Marcin Kowanetz, et al.Pageof 2